News

ProVerum’s ProVee system could offer patients a safe and effective treatment without the need for highly invasive surgery.
ProVerum has raised $80 million in venture capital funding to complete the development of its minimally invasive, stent-like implant to relieve the urinary symptoms of an enlarged prostat | The Dublin ...
WEST COLUMBIA, S.C. — For older men, the symptoms of an enlarged prostate can be a real nuisance. Benign prostatic hyperplasia (BPH)—is a condition in men in which the prostate gland is ...
Common symptoms of enlarged prostate include frequent and urgent urination, trouble starting a urine stream, urinary retention, urinary incontinence and more. 2 Interestingly, the size of the ...
The 2016-founded Trinity College Dublin spin-out is behind ProVee, a minimally invasive solution for treating benign ...
Common symptoms of enlarged prostate include frequent and urgent urination, trouble starting a urine stream, urinary retention, urinary incontinence and more. 2 Interestingly, the size of the ...
When symptoms arise, Mulroy encourages men to schedule a medical exam to explore underlying causes and treatment options. It’s also important to discuss family history because genetics can be a risk ...
ProVerum announced today that it closed an $80 million Series B equity financing to support its benign prostatic hyperplasia ...
ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the closing of an $80 million Series B ...
The sNDA is supported by data from the phase 3 URO-901-3005 study (ClinicalTrials.gov Identifier: NCT03902080), which included 1105 men with OAB symptoms receiving pharmacological therapy for BPH ...
At 3 months follow-up, the patient’s prostate volume dropped to 270 mL, his BPH symptoms were mild, and his quality of life score had improved from “terrible” to “pleased.” ...